Cancer Vaccine
IL-18-secreting fibroblasts prolong survival of tumor-bearing mice
Published in Immunotherapy Weekly, September 8th, 2004
"There is currently much interest in generating cytotoxic T lymphocyte (CTL) responses against tumor antigens as a therapy for cancer. In this study mouse fibroblasts (H-2b) were genetically modified to express a costimulatory B7.1 and a mature interleukin (IL)-18, and then loaded with an ovalbumin (OVA) epitope (SIINFEKL, H-2Kb restricted) as a model antigen, and tested for the induction of OVA-specific CTLs in C57BL/6 mice (H-2b). The genetically modified fibroblasts...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2004-09-08)
More Articles from Immunotherapy Weekly
- AIDS/HIV Vaccine
Hemagglutinating virus protein induces immune response with HIV vaccine - Allergies
Softening agent from PVC cause of asthma and allergic symptoms among children - Skin Cancer
Malignant melanomas increasing in teenagers and young adults - Tuberculosis Vaccine
New vaccines against tuberculosis entering human clinical trials - Vaccine Development
New evidence on antigen presenting cells and antigens reviewed - AIDS Therapy
Patient enrollment completed in phase I/II trial in AIDS - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
